Pathstone Family Office’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $638K | Buy |
+62,564
| New | +$638K | ﹤0.01% | 927 |
|
|
2023
Q1 | – | Sell |
-11,780
| Closed | -$632K | – | 1471 |
|
|
2022
Q4 | $632K | Sell |
11,780
-8,474
| -42% | -$454K | 0.01% | 994 |
|
|
2022
Q3 | $164K | Buy |
+20,254
| New | +$164K | ﹤0.01% | 1369 |
|
|
2021
Q1 | – | Sell |
-519
| Closed | -$5K | – | 1263 |
|
|
2020
Q4 | $5K | Sell |
519
-3,000
| -85% | -$28.9K | ﹤0.01% | 945 |
|
|
2020
Q3 | $32K | Buy |
3,519
+3,000
| +578% | +$27.3K | ﹤0.01% | 417 |
|
|
2020
Q2 | $6K | Hold |
519
| – | – | ﹤0.01% | 565 |
|
|
2020
Q1 | $5K | Buy |
+519
| New | +$5K | ﹤0.01% | 622 |
|
|
2019
Q4 | – | Sell |
-519
| Closed | -$4K | – | 611 |
|
|
2019
Q3 | $4K | Hold |
519
| – | – | ﹤0.01% | 547 |
|
|
2019
Q2 | $5K | Hold |
519
| – | – | ﹤0.01% | 563 |
|
|
2019
Q1 | $8K | Hold |
519
| – | – | ﹤0.01% | 543 |
|
|
2018
Q4 | $8K | Buy |
519
+309
| +147% | +$4.76K | ﹤0.01% | 348 |
|
|
2018
Q3 | $5K | Buy |
+210
| New | +$5K | ﹤0.01% | 183 |
|
|
2014
Q4 | – | Sell |
-265
| Closed | -$14K | – | 239 |
|
|
2014
Q3 | $14K | Buy |
+265
| New | +$14K | 0.04% | 181 |
|